Approximately 80% of GIST cases harbor activating mutations in the stem cell factor receptor (KIT) receptor tyrosine kinase gene, while 5%–10% involve mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene (Dhillon, 2020). This evidence concerns the gene KIT and gastrointestinal stromal tumor.